Lucid Diagnostics (LUCD) Research & Development (2020 - 2026)
Lucid Diagnostics (LUCD) posted Research & Development of $5.0 million for Q1 2026, up 174.78% on a QoQ basis from -$6.7 million in Q4 2025, and up 22.93% year-over-year from $4.1 million in Q1 2025.
Lucid Diagnostics (LUCD) Research & Development (2020 - 2026) Analysis & Trends
Lucid Diagnostics' Research & Development history runs 7 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- Quarterly Research & Development rose 22.93% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $840000.0 (down 95.59% YoY) and the FY2025 annual result came in at $5.7 million, down 65.51% from the prior year.
- Research & Development was $5.0 million for Q1 2026 at Lucid Diagnostics, up from -$6.7 million in the prior quarter.
- Across five years, Research & Development topped out at $11.9 million in Q4 2024 and bottomed at -$6.7 million in Q4 2025.
- A 5-year average of $3.3 million and a median of $2.9 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 1004.87% — and 2025, when it sank 156.1%.
- Lucid Diagnostics' Research & Development stood at $5.0 million in 2022, then surged by 120.83% to $11.1 million in 2023, then gained by 7.71% to $11.9 million in 2024, then sank by 156.1% to -$6.7 million in 2025, then surged by 174.78% to $5.0 million in 2026.
- Business Quant data shows LUCD's Research & Development at $5.0 million in Q1 2026, -$6.7 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | -6.69 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 4.07 Mn |
| Dec 31, 2024 | 11.92 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 11.07 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 4.03 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 5.01 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 3.87 Mn |
| Mar 31, 2022 | 2.88 Mn |
| Dec 31, 2021 | -554,000.00 |
| Sep 30, 2021 | 2.19 Mn |
| Jun 30, 2021 | 1.02 Mn |